Followers | 101 |
Posts | 13186 |
Boards Moderated | 0 |
Alias Born | 06/01/2013 |
Sunday, May 02, 2021 5:58:09 PM
Relief is a biopharmaceutical company founded by former Merck executives (Serono division) whose objective is to provide patients with therapeutic relief in serious diseases with high unmet medical need.
https://relieftherapeutics.com/company
Relief Therapeutics: In-Licensing Agreement with Merck
https://www.startupticker.ch/en/news/september-2015/relief-therapeutics-in-licensing-agreement-with-merck
Relief Therapeutics SA has executed, on 28 August 2015, a license agreement with Ares Trading SA, a wholly-owned subsidiary of Merck KGaA ("Merck”), for the exclusive, worldwide right to research, develop, use and commercialize atexakin alfa ("Atexakin”, or the "Molecule” or "SON-080” or the "Asset”). Atexakin is a low-dosage formulation of interleukin-6 (IL-6), a natural mammalian cytokine of 185 amino acids with pleiotropic functions in different tissues and organs for which clinical Phase I/II studies were conducted in thrombocytopenic cancer patients by Serono International ("Serono”), later acquired by Merck. Additional pre-clinical results generated by Serono in specific animal models have demonstrated the ability of Atexakin to regrow nerves and reinstate their normal functions, suggesting its potential to treat a cluster of diseases referred to as neuropathies.
https://markets.businessinsider.com/news/stocks/relief-therapeutics-holding-sa-announces-divestment-of-its-subsidiary-relief-therapeutics-sa-to-sonnet-biotherapeutics-inc-to-ensure-the-development-of-atexakin-alpha-interleukin-6-1028436854
About NeuroRx, Inc.
drug development projects for Merck, Allergan, Pharmacia, Pfizer, Novartis, and Mannkind,
https://www.marketscreener.com/quote/stock/RELIEF-THERAPEUTICS-HOLDI-120797827/news/Relief-Therapeutics-nbsp-C-O-R-R-E-C-T-I-O-N-NeuroRx-32822986/
RELIEF COMMENTS ON CERTAIN STATEMENTS MADE BY NEURORX, INC. IN THE AMENDED FORM S-4 FILING OF BIG ROCK PARTNERS ACQUISITION CORP.
19 April 2021
https://relieftherapeutics.com/newsblog/relief-comments-on-certain-statements-made-by-neurorx-inc-in-the-amended-form-s-4-filing-of-big-rock-partners-acquisition-corp
MERCK SERONO SA AND ARES TRADING SA GENERALCONDITIONS OF PURCHASE (GOODS/SERVICES)
https://webcache.googleusercontent.com/search?q=cache:pIaIkxFkE8oJ:https://www.merckgroup.com/content/dam/web/corporate/non-images/company/contacts/supplier/en/standard-tac/Swiss_Standard_TaC_EN.pdf+&cd=9&hl=en&ct=clnk&gl=us
https://www.google.com/maps/place/Ares+Trading+SA+%7C/@46.429311,6.0492896,10.25z/data=!4m5!3m4!1s0x478c5d8d54ecdb89:0xc31d65a162fb3ad1!8m2!3d46.3839803!4d6.2089816
Change of name from 'Ares Trading SA' to 'ARES TRADING SA'
https://opencorporates.com/companies/ch/8343
Recent MYMX News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 01/02/2024 06:16:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 01:00:38 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/13/2023 05:15:20 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 01:53:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2023 08:42:46 PM
- Form SC 13E3 - Going private transaction by certain issuers • Edgar (US Regulatory) • 10/17/2023 07:08:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 01:00:41 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 10:02:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2023 09:01:04 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM